Ionis Pharmaceuticals (IONS) Equity Ratio (2009 - 2026)

Ionis Pharmaceuticals' Equity Ratio history runs 18 years deep, the most recent figure standing at 0.14 for Q1 2026.

• In Q1 2026, Equity Ratio fell 15.78% year-over-year to 0.14; the TTM figure through Mar 2026 stood at 0.14 (down 15.78% YoY), while the FY2025 annual figure was 0.14, down 29.14% from the prior year.
• Equity Ratio was 0.14 for Q1 2026 at Ionis Pharmaceuticals, up from 0.14 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.28 in Q1 2022 to a low of 0.1 in Q2 2024.
• Historically, Equity Ratio has averaged 0.18 across 5 years, with a median of 0.17 in 2025.
• The sharpest annual moves came in 2023 and 2025: Equity Ratio slumped 56.19% in 2023, then surged 115.97% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.23 in 2022, then plunged by 42.8% to 0.13 in 2023, then jumped by 51.46% to 0.2 in 2024, then fell by 29.14% to 0.14 in 2025, then increased by 2.63% to 0.14 in 2026.
• The last three Equity Ratio figures came in at 0.14 (Q1 2026), 0.14 (Q4 2025), and 0.2 (Q3 2025), per Business Quant data.